Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis

Conatus Pharmaceuticals Inc. · 2016
ClinicalTrials.gov · Datasets · License: Public Domain · 2016
Open Source ↗
fibrosisliver-diseases
non-alcoholic steatohepatitis, fibrosis, liver diseases, nash, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1010277
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.